Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1499657rdf:typepubmed:Citationlld:pubmed
pubmed-article:1499657lifeskim:mentionsumls-concept:C0999699lld:lifeskim
pubmed-article:1499657lifeskim:mentionsumls-concept:C0003847lld:lifeskim
pubmed-article:1499657lifeskim:mentionsumls-concept:C0020885lld:lifeskim
pubmed-article:1499657lifeskim:mentionsumls-concept:C0042401lld:lifeskim
pubmed-article:1499657lifeskim:mentionsumls-concept:C0034826lld:lifeskim
pubmed-article:1499657lifeskim:mentionsumls-concept:C0086597lld:lifeskim
pubmed-article:1499657lifeskim:mentionsumls-concept:C0242940lld:lifeskim
pubmed-article:1499657lifeskim:mentionsumls-concept:C1515025lld:lifeskim
pubmed-article:1499657lifeskim:mentionsumls-concept:C1524063lld:lifeskim
pubmed-article:1499657lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:1499657lifeskim:mentionsumls-concept:C0731521lld:lifeskim
pubmed-article:1499657pubmed:issue1lld:pubmed
pubmed-article:1499657pubmed:dateCreated1992-9-14lld:pubmed
pubmed-article:1499657pubmed:abstractTextMuscarinic receptors of resistance vessels (submucosal arterioles, outside diameter 50-75 microns) from the guinea-pig small intestine were investigated in vitro using a computer-assisted videomicroscopy system (Diamtrak). The muscarinic receptor which mediates vasodilation of precontracted [U-46619 (300 nM) or (-)-noradrenaline (10 microM)] arterioles was characterized with several muscarinic agonists and subtype-selective antagonists. The following agonists all produced equivalent maximum vasodilation (given in rank order of potency): acetylcholine = arecaidine propargyl ester (APE) greater than oxotremorine = (+/-)-muscarine = (+/-)-methacholine greater than carbachol greater than 4-[[N-(4-chlorophenyl)carbamoyl]oxy]-2-butynyltrimethylammonium iodide (4-Cl-McN-A-343). 4-[[N-(3-Chlorophenyl)-carbamoyl]oxy]-2-butynyltrimethylammonium chloride (McN-A-343) and N-ethyl-guvacine propargyl ester (NEN-APE) produced minimal or no arteriolar vasodilation. The muscarinic antagonists pirenzepine, (+-)-5,11-dihydro-11-[[[2-[2-((dipropylamino)methyl)-1-piperidinyl] ethyl]amino]-carbonyl]-6H-pyrido(2,3-b)(1,4)-benzodiazepin-6-one (AF-DX 384), 11-[[4-[4-(diethylamino)butyl]-1-piperidinyl]acetyl]-5,11-dihydro- 6H-pyrido(2,3-b)(1,4)-benzodiazepin-6-one (AQ-RA 741), p-fluorohexahydro-sila-difenidol (p-F-HHSiD), 4-diphenylacetoxy-N-methylpiperidine methiodide (4-DAMP) and (R)- and (S)-hexahydro-difenidol [(R)-HHD, (S)-HHD] shifted the muscarine, methacholine or carbachol dose-response curve to the right in a competitive manner. Schild analysis of the data yielded pA2 values for pirenzepine (6.74/6.9), AF-DX 384 (6.72), AQ-RA 741 (6.58), p-F-HHSiD (7.53/7.57), 4-DAMP (9.06), (R)-HHD (7.88/8.32) and (S)-HHD (5.52/5.88). Thus, it can be concluded that submucosal arterioles possess only the M3 functional muscarinic receptor, the activation of which causes blood vessel dilation.(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:1499657pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1499657pubmed:languageenglld:pubmed
pubmed-article:1499657pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1499657pubmed:citationSubsetIMlld:pubmed
pubmed-article:1499657pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1499657pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1499657pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1499657pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1499657pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1499657pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1499657pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1499657pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1499657pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1499657pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1499657pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1499657pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1499657pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1499657pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1499657pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1499657pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1499657pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1499657pubmed:statusMEDLINElld:pubmed
pubmed-article:1499657pubmed:monthMarlld:pubmed
pubmed-article:1499657pubmed:issn0014-2999lld:pubmed
pubmed-article:1499657pubmed:authorpubmed-author:MutschlerEElld:pubmed
pubmed-article:1499657pubmed:authorpubmed-author:TackeRRlld:pubmed
pubmed-article:1499657pubmed:authorpubmed-author:MoserUUlld:pubmed
pubmed-article:1499657pubmed:authorpubmed-author:LambrechtGGlld:pubmed
pubmed-article:1499657pubmed:authorpubmed-author:BungardtEElld:pubmed
pubmed-article:1499657pubmed:authorpubmed-author:SurprenantAAlld:pubmed
pubmed-article:1499657pubmed:authorpubmed-author:FeifelRRlld:pubmed
pubmed-article:1499657pubmed:authorpubmed-author:VockertEElld:pubmed
pubmed-article:1499657pubmed:issnTypePrintlld:pubmed
pubmed-article:1499657pubmed:day17lld:pubmed
pubmed-article:1499657pubmed:volume213lld:pubmed
pubmed-article:1499657pubmed:ownerNLMlld:pubmed
pubmed-article:1499657pubmed:authorsCompleteYlld:pubmed
pubmed-article:1499657pubmed:pagination53-61lld:pubmed
pubmed-article:1499657pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:1499657pubmed:meshHeadingpubmed-meshheading:1499657-...lld:pubmed
pubmed-article:1499657pubmed:meshHeadingpubmed-meshheading:1499657-...lld:pubmed
pubmed-article:1499657pubmed:meshHeadingpubmed-meshheading:1499657-...lld:pubmed
pubmed-article:1499657pubmed:meshHeadingpubmed-meshheading:1499657-...lld:pubmed
pubmed-article:1499657pubmed:meshHeadingpubmed-meshheading:1499657-...lld:pubmed
pubmed-article:1499657pubmed:meshHeadingpubmed-meshheading:1499657-...lld:pubmed
pubmed-article:1499657pubmed:meshHeadingpubmed-meshheading:1499657-...lld:pubmed
pubmed-article:1499657pubmed:meshHeadingpubmed-meshheading:1499657-...lld:pubmed
pubmed-article:1499657pubmed:meshHeadingpubmed-meshheading:1499657-...lld:pubmed
pubmed-article:1499657pubmed:meshHeadingpubmed-meshheading:1499657-...lld:pubmed
pubmed-article:1499657pubmed:meshHeadingpubmed-meshheading:1499657-...lld:pubmed
pubmed-article:1499657pubmed:meshHeadingpubmed-meshheading:1499657-...lld:pubmed
pubmed-article:1499657pubmed:meshHeadingpubmed-meshheading:1499657-...lld:pubmed
pubmed-article:1499657pubmed:meshHeadingpubmed-meshheading:1499657-...lld:pubmed
pubmed-article:1499657pubmed:meshHeadingpubmed-meshheading:1499657-...lld:pubmed
pubmed-article:1499657pubmed:meshHeadingpubmed-meshheading:1499657-...lld:pubmed
pubmed-article:1499657pubmed:meshHeadingpubmed-meshheading:1499657-...lld:pubmed
pubmed-article:1499657pubmed:meshHeadingpubmed-meshheading:1499657-...lld:pubmed
pubmed-article:1499657pubmed:meshHeadingpubmed-meshheading:1499657-...lld:pubmed
pubmed-article:1499657pubmed:year1992lld:pubmed
pubmed-article:1499657pubmed:articleTitleCharacterization of muscarinic receptors mediating vasodilation in guinea-pig ileum submucosal arterioles by the use of computer-assisted videomicroscopy.lld:pubmed
pubmed-article:1499657pubmed:affiliationDepartment of Pharmacology, University of Frankfurt, Germany.lld:pubmed
pubmed-article:1499657pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1499657pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:1499657pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed